The HAUSP activators constitute a distinctive group of compounds strategically designed to modulate the activity of the deubiquitinase HAUSP (Herpesvirus-associated ubiquitin-specific protease). These chemicals exert their effects through precise interactions with various cellular pathways, orchestrating a sophisticated regulatory network that culminates in the activation of HAUSP. One exemplary compound within this class is HBX 41,108, which acts as a HAUSP activator by inhibiting the ubiquitin-proteasome system. By specifically targeting deubiquitinases, HBX 41,108 disrupts the degradation pathway of HAUSP, leading to the stabilization of HAUSP protein levels. This stabilization, in turn, enhances the deubiquitinase activity of HAUSP, allowing it to play a more pronounced role in cellular protein regulation.
Another notable member of this chemical class is PR-619, a broad-spectrum deubiquitinase inhibitor. PR-619 activates HAUSP by disrupting the removal of ubiquitin chains from HAUSP, thereby stabilizing its protein levels. This stabilization promotes the deubiquitinase activity of HAUSP, influencing cellular pathways involved in protein degradation and turnover. These HAUSP activators collectively exemplify the intricate interplay between chemical compounds and cellular regulatory networks. Understanding the specific biochemical pathways influenced by each compound provides valuable insights into the molecular mechanisms orchestrating HAUSP activation. This detailed knowledge of HAUSP activators opens avenues for targeted interventions in cellular processes and applications in research and biotechnology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $200.00 | 1 | |
UCH-L1 Inhibitor indirectly activates HAUSP by altering proteostasis, thereby influencing HAUSP's activity in protein degradation pathways. | ||||||
P005091 | 882257-11-6 | sc-478535 | 10 mg | $155.00 | ||
P5091 activates HAUSP by inhibiting the ubiquitin-proteasome system. It specifically targets deubiquitinases, preventing HAUSP degradation and leading to increased protein levels and enhanced deubiquitinase activity. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 inhibits ubiquitin-activating enzyme E1, indirectly activating HAUSP by increasing the need for HAUSP-mediated deubiquitination in response to disrupted ubiquitin signaling and protein degradation pathways. | ||||||